CSF1 and ovarian cancer: Previously, we observed that (i) androgen signaling promotes ovarian cancer development9, and (ii) CSF1/CSF1R and ErbB4 proteins were overexpressed in the ovarian tissues of HR women compared to LR, and this overexpression was reversed in those HR women treated with flutamide9,10.